Dr. Naresh Desireddi, MD
What this data tells you about Dr. Desireddi
Dr. Naresh Desireddi is an urology physician in Lakeway, TX, with 19 years in practice. Based on federal Medicare data, Dr. Desireddi performed 8,040 Medicare services across 2,252 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desireddi received a total of $6,614 from 51 pharmaceutical and/or device companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desireddi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,180 | $19 | $43 |
| Contrast dye for imaging (iodine-based) | 1,200 | $0 | $1 |
| Office visit, established patient (30-39 min) | 686 | $91 | $249 |
| Chronic care management, first 20 min/month | 466 | $45 | $77 |
| Automated urinalysis | 459 | $2 | $7 |
| Blood draw (venipuncture) | 400 | $8 | $15 |
| Bladder ultrasound after voiding | 261 | $8 | $44 |
| Chronic care management, additional 20 min/month | 252 | $35 | $77 |
| Limited ultrasound scan of pelvis | 199 | $35 | $110 |
| Ceftriaxone antibiotic injection | 140 | $0 | $3 |
| New patient office visit (45-59 min) | 108 | $112 | $380 |
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $188 | $477 |
| Office visit, established patient (20-29 min) | 84 | $70 | $168 |
| Ultrasound scan of pelvic region through rectum | 79 | $112 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $136 | $2,000 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 44 | $42 | $82 |
| Biopsy of prostate gland | 36 | $193 | $508 |
| Office visit, established patient, complex (40-54 min) | 35 | $136 | $336 |
| Complete ultrasound scan behind abdominal cavity | 34 | $39 | $211 |
| Electronic assessment of bladder emptying | 27 | $4 | $122 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 26 | $28 | $76 |
| Imaging of urinary tract following injection of a contrast agent | 25 | $20 | $191 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 24 | $112 | $433 |
| Insertion of device into abdomen with pressure and urine flow rate study | 24 | $53 | $156 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 19 | $14 | $289 |
| Simple bladder irrigation and/or instillation | 16 | $58 | $194 |
| Ct scan of abdomen and pelvis without contrast | 16 | $72 | $390 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $345 | $972 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 14 | $554 | $4,286 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desireddi is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desireddi experienced with denosumab injection (prolia/xgeva)?
Does Dr. Desireddi receive payments from pharmaceutical companies?
How do Dr. Desireddi's costs compare to other urology physicians in Lakeway?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology